Urinary red blood cell-derived microparticles and phosphatidylserine-exposing red blood cells in glomerular and non-glomerular hematuria patients.
flow cytometry
hematuria
microparticle
phosphatidylserine
urinalysis
Journal
Cytometry. Part B, Clinical cytometry
ISSN: 1552-4957
Titre abrégé: Cytometry B Clin Cytom
Pays: United States
ID NLM: 101235690
Informations de publication
Date de publication:
09 2022
09 2022
Historique:
revised:
20
04
2022
received:
07
02
2022
accepted:
23
05
2022
pubmed:
16
6
2022
medline:
17
9
2022
entrez:
15
6
2022
Statut:
ppublish
Résumé
Distinguishing glomerular hematuria (GH) from non-glomerular hematuria (NGH) is important for treating the cause of hematuria. We aimed to determine red blood cell-derived microparticles (RMPs) and phosphatidylserine (PS)-exposing red blood cells (RBCs) and evaluate their use for diagnosing GH and NGH patients. All patients received a physical assessment and urological examination. Dysmorphic RBCs (dRBCs) and acanthocytes were examined using a light microscope. The urinary RMPs and PS-exposing RBCs were determined using flow cytometry. The ratio of RMPs to RBCs was higher in GH patients (n = 29) than in NGH patients (n = 29) (1.06 vs. 0.18). The value of the sum of the PS-exposing RBCs plus RMPs divided by the number of RBCs was higher in GH patients than in NGH patients (48.3% vs. 19.4%). The percentage of RBCs was higher in GH patients than in NGH patients (54.5% vs. 21.8%). Similarly, both the percentages of acanthocytes and of non-acanthocytes were higher in GH patients than in NGH patients (29% vs. 7.7% and 25.4% vs. 14.2%, respectively). The ROC-AUC of the number of PS-exposing RBCs plus RMPs divided by the number of RBCs was 0.9 (95% CI, 0.82-0.97), and the RMPs:RBCs ratio was 0.88 (95% CI, 0.79-0.98). The ROC-AUCs of the dRBCs and acanthocytes were 0.85 (95% CI, 0.78-0.95) and 0.88 (95% CI, 0.8-0.97), respectively. Patients with GH have higher numbers of urinary RMPs and PS-exposing RBCs. These parameters have the potential to be predictive tools for classifying GH in the future.
Sections du résumé
BACKGROUND
Distinguishing glomerular hematuria (GH) from non-glomerular hematuria (NGH) is important for treating the cause of hematuria. We aimed to determine red blood cell-derived microparticles (RMPs) and phosphatidylserine (PS)-exposing red blood cells (RBCs) and evaluate their use for diagnosing GH and NGH patients.
METHODS
All patients received a physical assessment and urological examination. Dysmorphic RBCs (dRBCs) and acanthocytes were examined using a light microscope. The urinary RMPs and PS-exposing RBCs were determined using flow cytometry.
RESULTS
The ratio of RMPs to RBCs was higher in GH patients (n = 29) than in NGH patients (n = 29) (1.06 vs. 0.18). The value of the sum of the PS-exposing RBCs plus RMPs divided by the number of RBCs was higher in GH patients than in NGH patients (48.3% vs. 19.4%). The percentage of RBCs was higher in GH patients than in NGH patients (54.5% vs. 21.8%). Similarly, both the percentages of acanthocytes and of non-acanthocytes were higher in GH patients than in NGH patients (29% vs. 7.7% and 25.4% vs. 14.2%, respectively). The ROC-AUC of the number of PS-exposing RBCs plus RMPs divided by the number of RBCs was 0.9 (95% CI, 0.82-0.97), and the RMPs:RBCs ratio was 0.88 (95% CI, 0.79-0.98). The ROC-AUCs of the dRBCs and acanthocytes were 0.85 (95% CI, 0.78-0.95) and 0.88 (95% CI, 0.8-0.97), respectively.
CONCLUSIONS
Patients with GH have higher numbers of urinary RMPs and PS-exposing RBCs. These parameters have the potential to be predictive tools for classifying GH in the future.
Identifiants
pubmed: 35703591
doi: 10.1002/cyto.b.22083
doi:
Substances chimiques
Phosphatidylserines
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
370-376Informations de copyright
© 2022 International Clinical Cytometry Society.
Références
Becker, G. J., Garigali, G., & Fogazzi, G. B. (2016). Advances in urine microscopy. American Journal of Kidney Diseases, 67, 954-964.
Bhatt, N. R., Davis, N. F., Nolan, W. J., Flynn, R. J., McDermott, T., Thomas, A. Z., & Manecksha, R. P. (2018). Incidence of visible hematuria among antithrombotic agents: A systematic review of over 175,000 patients. Urology, 114, 27-32.
Bosman, G. J., Lasonder, E., Luten, M., Roerdinkholder-Stoelwinder, B., Novotný, V. M., Bos, H., & De Grip, W. J. (2008). The proteome of red cell membranes and vesicles during storage in blood bank conditions. Transfusion, 48, 827-835.
Chu-Su, Y., Shukuya, K., Yokoyama, T., Lin, W. C., Chiang, C. K., & Lin, C. W. (2017). Enhancing the detection of dysmorphic red blood cells and renal tubular epithelial cells with a modified urinalysis protocol. Scientific Reports, 7, 40521.
Crop, M. J., de Rijke, Y. B., Verhagen, P. C., Cransberg, K., & Zietse, R. (2010). Diagnostic value of urinary dysmorphic erythrocytes in clinical practice. Nephron. Clinical Practice, 115, c203-c212.
Dantzler, W. H., Layton, A. T., Layton, H. E., & Pannabecker, T. L. (2014). Urine-concentrating mechanism in the inner medulla: Function of the thin limbs of the loops of Henle. Clinical Journal of the American Society of Nephrology, 9, 1781-1789.
Gatidis, S., Borst, O., Föller, M., & Lang, F. (2010). Effect of osmotic shock and urea on phosphatidylserine scrambling in thrombocyte cell membranes. American Journal of Physiology. Cell Physiology, 299, C111-C118.
Gatidis, S., Zelenak, C., Fajol, A., Lang, E., Jilani, K., Michael, D., Qadri, S. M., & Lang, F. (2011). p38 MAPK activation and function following osmotic shock of erythrocytes. Cellular Physiology and Biochemistry, 28, 1279-1286.
Georgatzakou, H. T., Pavlou, E. G., Papageorgiou, E. G., Papassideri, I. S., Kriebardis, A. G., & Antonelou, M. H. (2020). The multi-faced extracellular vesicles in the plasma of chronic kidney disease patients. Frontiers in Cell and Development Biology, 8, 227.
Gonzales, P., Pisitkun, T., & Knepper, M. A. (2008). Urinary exosomes: Is there a future? Nephrology, Dialysis, Transplantation, 23, 1799-1801.
Grossfeld, G. D., & Carroll, P. R. (1998). Evaluation of asymptomatic microscopic hematuria. The Urologic Clinics of North America, 25, 661-676.
Hamadah, A. M., Gharaibeh, K., Mara, K. C., Thompson, K. A., Lieske, J. C., Said, S., Nasr, S. H., & Leung, N. (2018). Urinalysis for the diagnosis of glomerulonephritis: Role of dysmorphic red blood cells. Nephrology, Dialysis, Transplantation, 33, 1397-1403.
Hugel, B., Martínez, M. C., Kunzelmann, C., & Freyssinet, J. M. (2005). Membrane microparticles: Two sides of the coin. Physiology (Bethesda), 20, 22-27.
Koo, K. C., Lee, K. S., Choi, A. R., Rha, K. H., Hong, S. J., & Chung, B. H. (2016). Diagnostic impact of dysmorphic red blood cells on evaluating microscopic hematuria: The urologist's perspective. International Urology and Nephrology, 48, 1021-1027.
Merchant, M. L., Rood, I. M., Deegens, J. K. J., & Klein, J. B. (2017). Isolation and characterization of urinary extracellular vesicles: Implications for biomarker discovery. Nature Reviews. Nephrology, 13, 731-749.
Morel, O., Toti, F., Hugel, B., Bakouboula, B., Camoin-Jau, L., Dignat-George, F., & Freyssinet, J. M. (2006). Procoagulant microparticles: Disrupting the vascular homeostasis equation? Arteriosclerosis, Thrombosis, and Vascular Biology, 26, 2594-2604.
Noulsri, E., Ardsiri, S., Lerdwana, S., & Pattanapanyasat, K. (2019). Comparison of phosphatidylserine-exposing red blood cells, fragmented red blood cells and red blood cell-derived microparticles in β-thalassemia/HbE patients. Laboratoriums Medizin, 50, 47-53.
Noulsri, E., Lerdwana, S., Kittisares, K., Palasuwan, A., & Palasuwan, D. (2017). Flow rate calibration to determine cell-derived microparticles and homogeneity of blood components. Transfusion and Apheresis Science, 56, 585-590.
Noulsri, E., Lerdwana, S., Palasuwan, D., & Palasuwan, A. (2021). Cell-derived microparticles in blood products from Thalassemic blood donors. Laboratoriums Medizin, 52, 150-157.
Noulsri, E., & Palasuwan, A. (2018). Effects of donor age, donor sex, blood-component processing, and storage on cell-derived microparticle concentrations in routine blood-component preparation. Transfusion and Apheresis Science, 57, 587-592.
Pang, A., Cui, Y., Chen, Y., Cheng, N., Delaney, M. K., Gu, M., Stojanovic-Terpo, A., Zhu, C., & Du, X. (2018). Shear-induced integrin signaling in platelet phosphatidylserine exposure, microvesicle release, and coagulation. Blood, 132, 533-543.
Peterson, L. M., & Reed, H. S. (2019). Hematuria. Primary Care, 46, 265-273.
Rubin, O., Canellini, G., Delobel, J., Lion, N., & Tissot, J. D. (2012). Red blood cell microparticles: Clinical relevance. Transfusion Medicine and Hemotherapy, 39, 342-347.
Said, A. S., & Doctor, A. (2017). Influence of red blood cell-derived microparticles upon vasoregulation. Blood Transfusion, 15, 522-534.
Sands, J. M., & Kokko, J. P. (1990). Countercurrent system. Kidney International, 38, 695-699.
Stewart, A., Urbaniak, S., Turner, M., & Bessos, H. (2005). The application of a new quantitative assay for the monitoring of integrin-associated protein CD47 on red blood cells during storage and comparison with the expression of CD47 and phosphatidylserine with flow cytometry. Transfusion, 45, 1496-1503.
Tesser Poloni, J. A., Bosan, I. B., Garigali, G., & Fogazzi, G. B. (2012). Urinary red blood cells: Not only glomerular or nonglomerular. Nephron. Clinical Practice, 120, c36-c41 discussion c41.
Vion, A. C., Ramkhelawon, B., Loyer, X., Chironi, G., Devue, C., Loirand, G., Tedgui, A., Lehoux, S., & Boulanger, C. M. (2013). Shear stress regulates endothelial microparticle release. Circulation Research, 112, 1323-1333.
Willekens, F. L., Werre, J. M., Groenen-Döpp, Y. A., Roerdinkholder-Stoelwinder, B., de Pauw, B., & Bosman, G. J. (2008). Erythrocyte vesiculation: A self-protective mechanism? British Journal of Haematology, 141, 549-556.